Ryvu Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RVU?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,917,437	8.29%
Individual Insiders	5,503,574	23.8%
General Public	5,559,943	24%
Institutions	10,139,194	43.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.45% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.5%	Allianz Asset Management GmbH	4,042,236	zł157.6m	0%	0.02%
17.4%	Pawel Przewiezlikowski	4,016,985	zł156.7m	-0.4%	no data
8.29%	BioNTech SE	1,917,437	zł74.8m	0%	no data
8.22%	Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.	1,900,000	zł74.1m	0%	0.15%
5.54%	Forum Towarzystwo Funduszy Inwestycyjnych S.A.	1,279,738	zł49.9m	0%	5.84%
4.15%	Norges Bank Investment Management	960,477	zł37.5m	0%	no data
3.57%	Boguslaw Sieczkowski	825,348	zł32.2m	0%	no data
1.94%	Goldman Sachs Asset Management, L.P.	448,717	zł17.5m	0%	no data
1.33%	Towarzystwo Funduszy Inwestycyjnych PZU SA	306,678	zł12.0m	0%	0.16%
1.27%	GAMMA PKO Towarzystwo Funduszy Inwestycyjnych SA	292,871	zł11.4m	0%	0.09%
1.16%	Krzysztof Brzózka	267,321	zł10.4m	0%	no data
0.79%	AXA Towarzystwo Funduszy Inwestycyjnych SA	181,984	zł7.1m	0%	0.39%
0.68%	Franklin Resources, Inc.	156,312	zł6.1m	0%	no data
0.54%	Pioneer Pekao Towarzystwo Funduszy Inwestycyjnych S.A	125,743	zł4.9m	0%	0.17%
0.52%	Rafal Chwast	121,115	zł4.7m	0%	no data
0.51%	Skarbiec TFI S.A.	117,913	zł4.6m	-0.05%	0.15%
0.4%	Tadeusz Wesolowski	92,975	zł3.6m	0%	no data
0.26%	Millennium TFI S.A.	61,056	zł2.4m	0%	0.31%
0.25%	Vatnak Vat-Ho	57,000	zł2.2m	33.3%	no data
0.23%	Union Investment TFI S.A	53,359	zł2.1m	0%	0.11%
0.22%	Piotr Romanowski	50,000	zł1.9m	0%	no data
0.21%	AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.	48,516	zł1.9m	0%	0.11%
0.18%	Powszechne Towarzystwo Emerytalne PZU SA	41,755	zł1.6m	0%	0.01%
0.17%	Kamil Sitarz	39,230	zł1.5m	0%	no data
0.17%	Santander Towarzystwo Funduszy Inwestycyjnych S.A.	38,996	zł1.5m	0%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 17:04
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ryvu Therapeutics S.A. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamil Kliszcz	Biuro maklerskie mBanku
Beata Szparaga-Wasniewska	Biuro maklerskie mBanku
Jonas Peciulis	Edison Investment Research